Global Cellular Health Screening Market valued at USD 2.6 billion in 2022, is anticipated to witness a CAGR of 9% by 2027
Cellular health screening or testing is one of the key factors of health based on major factors such as human lifestyle, environment, emotions and diet. It can be used to examine the inflammatory diseases such as allergies, asthma, arthritis, autoimmune diseases, or inflammatory gastrointestinal issues. This test further helps in examining the patient’s progress throughout the medical treatment and offer detailed reports to monitor and assess further improvements on a cellular level. Cellular health screening helps in determining the cellular health & function, fat mass, intra & extracellular fluid levels, cellular toxicity, and muscle mass, etc.
Technological Developments and Innovations in the Global Cellular Health Screening Market
Growing Research Activities to Trigger the Advancements and Developments in the Cellular Health Screening Market
Consistent growth in the global cellular health screening market is expected to be driven by the rising number of public awareness campaigns targeted at making people aware on the symptoms of chronic diseases and how
to prevent them to further reduce various diseases and epidemics. Due to rising patient
awareness and an increased demand, there is a decent demand for novel cellular
health screening kits and services which has forced the researchers to emphasize on the market advancements and develop advanced diagnostic tests and kits.
- In February 2023, Duke-NUS Medical School announced that Scientists at the Duke-NUS Medical School, National Heart Centre Singapore (NHCS) and colleagues in Singapore, China and the US have developed a test to quickly and precisely measure the length of a single telomere. The new approach is set to be used as a predictive biomarker for human ageing and disease at the individual level.
Competitive Landscape Analysis: Cellular Health Screening Market
The global cellular health screening market is marked by the presence of leading and established market players as listed below: -
- Quest Diagnostics (US)
- Telomere Diagnostics (US)
- SpectraCell Laboratories (US)
- Genova Diagnostics (US)
- LabCorp Holdings (US)
- Repeat Diagnostics, Inc. (Canada)
- Life Length (Spain)
The global cellular health screening market is an emerging market and is poised to gain a consistent momentum in the coming years due to a major focus on healthcare advancements, global acceptance & growing awareness on preventive healthcare, rapidly growing aging population, and major focus of key market players to expand their global presence.
For instance,
By 2030, 1 person in every 6 people in the world will be aged 60 years and above. Currently, the share of the population aged 60 years and above will rise from 1 billion in 2020 to reach 1.4 billion. Aging increases the greater risk
of chronic diseases and infections which demands the preventive diagnostic
tests, thus driving the global growth of the cellular health screening market.
Get Detailed Insights on Cellular Health Screening Market with a FREE Sample Report @ https://meditechinsights.com/cellular-health-screening-market/
Comments
Post a Comment